Home | AACE Task Force | About Us | Contact Us Feedback

Approaches & Tools


Management of Hyperglycemia in the ICU Setting

Management of Hyperglycemia in the ICU Setting

Download Presentation

In this section you will find:

  • Slide Presentation – summarizing the available published intravenous insulin protocols and discussing the ideal candidates for intravenous insulin as well as guidelines for transitioning a patient from intravenous to subcutaneous regimens
  • Intravenous insulin protocols – Examples of published intravenous insulin protocols that have been demonstrated to be safe and efficacious; please note that many protocols are being re-worked in line with modified treatment goals
  • Reference list – and suggested Key Readings
  • Selected full text publications and abstracts

Key Points:

  • Intravenous insulin is the easiest and most precise way to achieve tight blood glucose control in this setting
  • A simple order to “titrate to a blood glucose of 180 mg/dl” is no longer sufficient. Even the most experienced ICU nurse will find it a challenge to properly titrate IV insulin to maintain euglycemia without specific and precise guidelines
  • Successful implementation of protocols requires:
    • Buy-in from key stakeholders (eg, critical care physicians, house staff, nursing, pharmacy, hospital administration, etc.)
    • Appropriate education through in-servicing of hospital staff
    • Ongoing monitoring of results
    • Support from endocrinologists for specific questions or when a patient does not respond to the protocol as expected

Finally:

It is important to keep in mind that these algorithms have never been directly compared in clinical trials. Therefore, in selecting a protocol, one should look for characteristics that are compatible with the institution in which it will be implemented.  Consideration should be given to factors such as whether or not the protocol is “dynamic” (ie, allows for variability in insulin requirements and accounts for rates of change in blood glucose concentrations; its user-friendliness/complexity; the need to perform basic calculations; and the suitability for various local computer systems). None of the examples provided are suitable for the treatment of diabetic ketoacidosis.  Lastly, because some patients in the intensive care unit may receive subcutaneous insulin, please see the section on the “Inpatient Non ICU” for specific subcutaneous insulin protocols.

 

Documents in this section

Date
Author
Document
2010
AACE
2009
AACE
2009
AACE
2009
AACE
2009
Falciglia
2009
Griesdale
2009
NICE-SUGAR
2009
Preiser
2008
Brunkhorst
2008
Kosiborod
2008
Treggiari
2008
Wiener
2007
Anthony
2007
Cook
2007
Hovorka
2007
Karon
2007
Nazer
2007
Reed
2006
AACE
2006
Braithwaite
2006
DeSantis
2006
Furnary
2006
Furnary
2006
Goldberg
2006
Hellman
2006
Hirsch
2006
Korytkowski
2006
Langley
2006
Olson
2006
Pittas
2006
Van den Berghe
2006
Van den Berghe
2006
Vanhorebeek
2006
Vriesendorp
2005
Ku
2005
Malmberg
2005
Moghissi
2005
Van den Berghe
2004
AACE
2004
Bode
2004
Braithwaite
2004
Clement
2004
Furnary
2004
Goldberg
2004
Hellman
2004
Krinsley
2004
Magee
2004
Malmberg
2004
Moghissi
2004
Pittas
2004
Van den Berghe
2003
Van den Berghe
2002
Markovitz
2001
Van den Berghe
1999
Malmberg
1997
Malmberg